Rubric Capital Management (New York)’s Adaptive Biotechnologies ADPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $72.9M | Sell |
6,256,847
-6,861,004
| -52% | -$79.9M | 1.1% | 23 |
|
|
2025
Q1 | $97.5M | Sell |
13,117,851
-1,482,149
| -10% | -$11M | 1.75% | 16 |
|
|
2024
Q4 | $87.5M | Buy |
14,600,000
+200,000
| +1% | +$1.2M | 1.12% | 15 |
|
|
2024
Q3 | $73.7M | Buy |
14,400,000
+400,000
| +3% | +$2.05M | 1.2% | 19 |
|
|
2024
Q2 | $50.7M | Buy |
14,000,000
+3,500,000
| +33% | +$12.7M | 1.33% | 30 |
|
|
2024
Q1 | $33.7M | Buy |
10,500,000
+7,637,271
| +267% | +$24.5M | 1% | 35 |
|
|
2023
Q4 | $14M | Buy |
+2,862,729
| New | +$14M | 0.29% | 43 |
|